Banyan Biomarkers
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Banyan Biomarkers sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Banyan Biomarkers: 8 sponsored US clinical trials, none currently recruiting.
Banyan Biomarkers sponsors 8 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. The most-studied condition in this pipeline is Traumatic Brain Injury, with 3 trials.
Upper-quartile sponsor footprint
Banyan Biomarkers sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
8 total, page 1 of 1
Evaluation of Biomarker Kinetics After Mild Brain Injury Trauma
NCT02541123
Evaluation OF Biomarkers OF Traumatic Brain Injury Extension Study
NCT02439736
Evaluation of Mild TBI in Collegiate Athletes
NCT02189525
Evaluation of Biomarkers of Traumatic Brain Injury
NCT01426919
A Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student Athletes
NCT01472042
Brain Injury Biomarkers in the General Population
NCT01786460
Biomarkers of Mild and Moderate Traumatic Brain Injury
NCT01295346
Biomarkers of Brain Injury: Magnitude and Outcome of Mild and Moderate TBI
NCT01786447
Therapeutic Areas
How the Banyan Biomarkers archive is shaped
8 indexed studies, none listed as recruiting (0% open); 7 completed (88%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Traumatic Brain Injury (3 trials), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Banyan Biomarkers: archived-pipeline peers nationwide
Peers matched on 8 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Banyan Biomarkers sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 archived trials
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Banyan Biomarkers page
8 registered trials is a research-attention snapshot, not an endorsement of Banyan Biomarkers or any single study.
- None of Banyan Biomarkers's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Traumatic Brain Injury is the condition Banyan Biomarkers studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Traumatic Brain Injury trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Banyan Biomarkers pipeline card: 8 registered trials from official public datasets.Report a data error.